Maria Fardis, Ph.D.

Maria Fardis, Ph.D.

DirectoratCRISPR Therapeutics AG· In proxies 2023–2025

Maria Fardis, Ph.D. sits on 1 public board.

Boards1

  • CRISPR Therapeutics AGDirector · 1 yr on the boardIndependentAudit, Directors and Executive—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. CRISPR Therapeutics AGPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role +32%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

Two people shown as one, or a wrong number?